Tumor progression occurs as a result of the clonal selection of cells in wh
ich somatic mutations have activated oncogenes or inactivated tumor suppres
sor genes leading to increased proliferation and/or survival within the hyp
oxic tumor microenvironment. Hypoxia-inducible factor 1 (HIF-1) is a transc
ription factor that mediates adaptive responses to reduced O-2 availability
, including angiogenesis and glycolysis. Expression of the O-2-regulated HI
F-1(alpha) subunit and HIF-1 transcriptional activity are increased dramati
cally in hypoxic cells. Recent studies indicate that many common tumor-spec
ific genetic alterations also lead to increased HIF-1 alpha expression and/
or activity. Thus, genetic and physiologic alterations within tumors act sy
nergistically to increase HIF-1 transcriptional activity, which appears to
play a critical role in the development of invasive and metastatic properti
es that define the lethal cancer phenotype.